When it comes to protecting companies intellectual property (IP) rights, businesses often take two distinct approaches, says João Paulo Miranda, Head of IP at Garrigues
The enactment of new legislation relating to the parallel import of medicines into Portugal has dramatically simplified the obligations of applicants and the duties of the Portuguese medicines regulator INFARMED, say António Pinto Leite
Businesses need to be aware of the need to protect their data from loss or ‘leakage’™ and understand that most issues arise internally rather than externally
The Portuguese Government’s attempts to promote the use of mediation and arbitration in intellectual and industrial property (IP) disputes are being driven by the continuing inefficiency of the country’s Commercial Courts, says Cé
Generic medicines are playing an increasingly important and prominent role in Portugal albeit the innovative pharmaceutical industry is responding
The global growth in online social networking is prompting US-based businesses to establish a permanent presence in Europe, and Spain is high on their agenda, says Marta Plana, Head of IT and IP at Osborne
A rise in regulatory pressure by the Portuguese medicine regulator, INFARMED, is prompting an increased questioning of its decisions.
Discussions during Iberian Lawyer’s recent forums for General Counsel and Managing Partners returned again and again to the tricky issue of the billable hour.
The upturn in disputes as a result of the global economic crisis is placing pressure on the international arbitration community to speed up processes and reduce costs, and is seeing in-house counsel increasingly take more
Following a Recommendation from the European Commission in April 2009 on remuneration policies, Portugal recently introduced changes to its personal income tax (PIT) and corporate income tax (CIT) legislation, with the aim of limiting excessive termination
